FR2324311B1 - - Google Patents

Info

Publication number
FR2324311B1
FR2324311B1 FR7528505A FR7528505A FR2324311B1 FR 2324311 B1 FR2324311 B1 FR 2324311B1 FR 7528505 A FR7528505 A FR 7528505A FR 7528505 A FR7528505 A FR 7528505A FR 2324311 B1 FR2324311 B1 FR 2324311B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7528505A
Other languages
French (fr)
Other versions
FR2324311A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7528505A priority Critical patent/FR2324311A1/fr
Publication of FR2324311A1 publication Critical patent/FR2324311A1/fr
Application granted granted Critical
Publication of FR2324311B1 publication Critical patent/FR2324311B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7528505A 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes Granted FR2324311A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7528505A FR2324311A1 (fr) 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7528505A FR2324311A1 (fr) 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Publications (2)

Publication Number Publication Date
FR2324311A1 FR2324311A1 (fr) 1977-04-15
FR2324311B1 true FR2324311B1 (enrdf_load_stackoverflow) 1980-06-06

Family

ID=9160094

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7528505A Granted FR2324311A1 (fr) 1975-09-17 1975-09-17 Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de mycobacteries et autres micro-organismes

Country Status (1)

Country Link
FR (1) FR2324311A1 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
EP0027260B1 (en) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptides, processes for their preparation and pharmaceutical compositions containing them
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus

Also Published As

Publication number Publication date
FR2324311A1 (fr) 1977-04-15

Similar Documents

Publication Publication Date Title
FI762876A7 (enrdf_load_stackoverflow)
FR2324311B1 (enrdf_load_stackoverflow)
FR2308831B3 (enrdf_load_stackoverflow)
JPS5252980U (enrdf_load_stackoverflow)
JPS5226382U (enrdf_load_stackoverflow)
JPS5218047U (enrdf_load_stackoverflow)
FR2330082B3 (enrdf_load_stackoverflow)
JPS5756066B2 (enrdf_load_stackoverflow)
JPS5544021B2 (enrdf_load_stackoverflow)
JPS5346685B2 (enrdf_load_stackoverflow)
JPS5282985U (enrdf_load_stackoverflow)
JPS5225824U (enrdf_load_stackoverflow)
JPS521453U (enrdf_load_stackoverflow)
JPS5273017U (enrdf_load_stackoverflow)
JPS5277795U (enrdf_load_stackoverflow)
JPS51119199U (enrdf_load_stackoverflow)
CH602596A5 (enrdf_load_stackoverflow)
CH600356A5 (enrdf_load_stackoverflow)
CH605297A5 (enrdf_load_stackoverflow)
CH605279A5 (enrdf_load_stackoverflow)
CH604889A5 (enrdf_load_stackoverflow)
CH604547A5 (enrdf_load_stackoverflow)
CH604465A5 (enrdf_load_stackoverflow)
CH603004A5 (enrdf_load_stackoverflow)
CH621230GA3 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
ST Notification of lapse
AR Application made for restoration
BR Restoration of rights
ST Notification of lapse